1. Home
  2. ITRM vs CPSH Comparison

ITRM vs CPSH Comparison

Compare ITRM & CPSH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ITRM
  • CPSH
  • Stock Information
  • Founded
  • ITRM 2015
  • CPSH 1984
  • Country
  • ITRM Ireland
  • CPSH United States
  • Employees
  • ITRM N/A
  • CPSH N/A
  • Industry
  • ITRM Biotechnology: Pharmaceutical Preparations
  • CPSH Building Materials
  • Sector
  • ITRM Health Care
  • CPSH Consumer Discretionary
  • Exchange
  • ITRM Nasdaq
  • CPSH Nasdaq
  • Market Cap
  • ITRM 40.0M
  • CPSH 36.6M
  • IPO Year
  • ITRM 2018
  • CPSH 1987
  • Fundamental
  • Price
  • ITRM $0.76
  • CPSH $3.10
  • Analyst Decision
  • ITRM Strong Buy
  • CPSH
  • Analyst Count
  • ITRM 2
  • CPSH 0
  • Target Price
  • ITRM $7.00
  • CPSH N/A
  • AVG Volume (30 Days)
  • ITRM 1.0M
  • CPSH 112.6K
  • Earning Date
  • ITRM 08-05-2025
  • CPSH 07-30-2025
  • Dividend Yield
  • ITRM N/A
  • CPSH N/A
  • EPS Growth
  • ITRM N/A
  • CPSH N/A
  • EPS
  • ITRM N/A
  • CPSH N/A
  • Revenue
  • ITRM N/A
  • CPSH $25,764,977.00
  • Revenue This Year
  • ITRM N/A
  • CPSH N/A
  • Revenue Next Year
  • ITRM $270.19
  • CPSH N/A
  • P/E Ratio
  • ITRM N/A
  • CPSH N/A
  • Revenue Growth
  • ITRM N/A
  • CPSH 7.46
  • 52 Week Low
  • ITRM $0.66
  • CPSH $1.29
  • 52 Week High
  • ITRM $3.02
  • CPSH $3.58
  • Technical
  • Relative Strength Index (RSI)
  • ITRM 41.71
  • CPSH 55.38
  • Support Level
  • ITRM $0.80
  • CPSH $3.12
  • Resistance Level
  • ITRM $0.91
  • CPSH $3.37
  • Average True Range (ATR)
  • ITRM 0.06
  • CPSH 0.25
  • MACD
  • ITRM 0.02
  • CPSH 0.02
  • Stochastic Oscillator
  • ITRM 41.08
  • CPSH 47.25

About ITRM Iterum Therapeutics plc

Iterum Therapeutics PLC is a pharmaceutical company dedicated to maximizing the commercial potential of Orlynvah, an oral-branded penem available in the United States and potentially the first and only oral and intravenous (IV) branded penem available globally. Its product Orlynvah has the potential to be a treatment for complicated urinary tract infections caused by the designated microorganisms, without the presence of known toxicities of some other antibiotics. The company operates in a single business segment, which is the development and commercialization of treatments for drug-resistant bacterial infections.

About CPSH CPS Technologies Corp.

CPS Technologies Corp provides material solutions to the transportation, automotive, energy, computing/Internet, telecommunications, aerospace, defense, and oil and gas end markets. Its primary material solution is metal matrix composites (MMCs), which are a class of materials consisting of a combination of metal and ceramic. The company designs, manufactures and sells custom MMC components, which manages the performance and reliability of systems in the end markets. It also provides baseplates and housings used in radar, satellite and avionics applications. The company provides lids and heat spreaders used with integrated circuits in Internet switches and routers.

Share on Social Networks: